Loading…
This event has ended. Visit the official site or create your own event on Sched.
The Virtual 16th Annual Meeting of ISMPP is June 16-18, 2020. All times are ET. REGISTER NOW! Fees are $720 USD. Registration ends June 5, 2020.
Register 10 attendees from the same company and receive a 10% discount AND your company will be recognized as a Champion Sponsor! Contact ismpp@ismpp.org to take advantage of this great offer!

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, June 16
 

10:00am EDT

Opening Remarks
Join us as we welcome you to the 16th Annual Meeting of ISMPP – delivered to you virtually! Catherine Skobe and Todd Parker will lead us through what to expect for the day and help you to best navigate the virtual meeting.

Speakers
avatar for Catherine Skobe

Catherine Skobe

Chair, ISMPP Board of Trustees, Senior Director, Publications Management Team, Pfizer
Catherine Skobe is currently Sr Director, Publications Innovative Solutions Lead at Pfizer and co-leads the Publications Management Team. She has been at Pfizer since 2007 working across Pfizer's portfolio in various therapeutic areas at every stage of the product development life... Read More →
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →


Tuesday June 16, 2020 10:00am - 10:10am EDT

10:10am EDT

The Future of Medical Communications – A Visual Journey
Our profession is evolving, and our remit is expanding. The technology that surrounds us will continue to stretch our thoughts about how healthcare professionals and patients will receive information and their preferences for engaging with it.
 
ISMPP is excited to feature a graphical representation of the future of medical communications over the next 5 years. What might our profession look like in 2025? Join us for a visual journey as a graphic artist creates an image that draws connections visually, communicates concepts powerfully, and reveals bold new ideas about the future of our profession.

Tuesday June 16, 2020 10:10am - 10:15am EDT

10:15am EDT

Keynote: 2020 and beyond: How the "open" research paradigm will impact the next generation research dissemination
Summary: 
The purpose of this session is to highlight the importance of open science in the next decade; its impact on how we communicate research and with whom; and the implications for industry as it seeks to navigate this new world. The paradigm shift will be particularly important for industry as mandates around data, code, protocols, etc change rapidly and patients and practitioners expect more and faster access to research findings.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning Objectives:
  • Understand what open science is
  • Understand how open science and open access related
  • Understand the impacts of this paradigm shift
  • Understand how publishers are navigating this shift

Speakers
avatar for Niamh O'Connor

Niamh O'Connor

Chief Publishing Officer, PLOS
Niamh is Chief Publishing Officer at PLOS, where she provides business leadership for the journals portfolio ensuring that it has a strong value proposition and advances PLOS’s vision and mission. Previously she was the Director of Publishing at the Biochemical Society/Portland... Read More →

Moderators
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →


Tuesday June 16, 2020 10:15am - 10:45am EDT

10:45am EDT

Break
Head to the Networking Chat section to connect with other attendees!

Tuesday June 16, 2020 10:45am - 11:00am EDT

11:00am EDT

For the Present Purpose: Using Medical Rhetoric to Enhance Scientific Communication in an Open World
Summary: 
Rhetorical studies of science and medicine offer tools for scientific communicators who seek to prevent misunderstandings across different audiences. Drawing on the published rhetorical literature, the speaker will describe specific elements of rhetorical study with potential importance to scientific communication functions such as publication planning, manuscript preparation, lay summaries, and editorial feedback. Of particular interest will be a description of differences in expectations between scientific audiences and those with a more normative understanding of medical terms. Further, the speaker will outline specific strategies and rationales for ethically integrating publication and communication planning into translational medical settings.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Leverage rhetorical strategies to improve communication in an open world
  • Identify critical terms and phrases that can benefit from additional explanation for lay and other non-expert audiences
  • Strategize more effective integration of publication planning across the development pipeline based on communication needs

Speakers
avatar for Lisa DeTora

Lisa DeTora

Associate Professor of Writing Studies and Rhetoric and Director, STEM Writing, Hofstra University
Lisa DeTora is an Associate Professor and the Director of STEM Writing at Hofstra University, where she teaches in writing studies, rhetoric, English, chemistry, biology, disability studies, sports science, and medical humanities. She also serves as guest faculty in narrative medicine... Read More →

Moderators
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →


Tuesday June 16, 2020 11:00am - 11:30am EDT

11:30am EDT

Break
Head over to the Brain Break section for games and activities to help you refresh your mind!

Tuesday June 16, 2020 11:30am - 11:45am EDT

11:45am EDT

Editor’s panel: I'm an Editor - Ask Me Anything!
Summary: 
As publishers overseeing high-impact websites, books and journals, we are frequently the front line for queries from scientific communicators on innovation and options in traditional and open publishing models, providing more clarity regarding who our readers are, opportunities for engaging readers with content, as well as on submitting manuscripts, peer-review, and post-publication services. By gathering delegate questions (in advance and during the session), we can reassure delegates on common publishing pain-points and provide an update on the progress to an open world as well as other opportunities from a range of publishers.

Learning objectives:
  • Update themselves on how publishers are supporting global open publishing initiatives and innovations to ensure better reader engagement with content
  • Further the conversation about the future of open publishing, e.g. open access, open peer review, plain-language summaries, data sharing, preprints
  • Understand the challenges and opportunities publishers face in providing enhanced data regarding our readers
  • Receive an overview of publisher advances that will make publishing their manuscript a smoother experience

Speakers
avatar for Caroline Halford

Caroline Halford

Digital Publishing Manager, Adis | Springer Healthcare Ltd.
Caroline is the Digital Publishing Manager for Springer Healthcare (part of Springer Nature), Chester, UK. Caroline represents the Adis portfolio of journals, including Advances in Therapy, Diabetes Therapy, CNS Drugs and PharmacoEconomics. She has been involved in the launch and... Read More →
avatar for Alan Moore

Alan Moore

Sales Director, Wolters Kluwer
Alan Moore is Sales Director at Wolters Kluwer. Alan’s career in medical publishing extends for more than 15 years, including roles in copy editing, subscription marketing, and commercial sales. He currently heads up the book special sales and commercial reprint sales teams at Wolters... Read More →
avatar for Shawn Morton

Shawn Morton

Senior Editorial Director, Health Sciences, Wiley
Shawn Morton is Senior Editorial Director for Health Science at John Wiley & Sons. Shawn has 30 years of industry experience acquiring, launching, and developing peer-reviewed journals; controlled circulation titles; books; and other ancillary products devoted to medical research... Read More →
avatar for Niamh O'Connor

Niamh O'Connor

Chief Publishing Officer, PLOS
Niamh is Chief Publishing Officer at PLOS, where she provides business leadership for the journals portfolio ensuring that it has a strong value proposition and advances PLOS’s vision and mission. Previously she was the Director of Publishing at the Biochemical Society/Portland... Read More →

Moderators
avatar for Kelly Soldavin

Kelly Soldavin

Medical Editor, Current Medical Research & Opinion, Taylor & Francis Group
Kelly Soldavin is a Medical Editor for the publisher Taylor & Francis and a member of their London-based Medicine & Health Editorial team. In this role, Kelly manages the journals Current Medical Research & Opinion and Journal of Drug Assessment and previously managed Journal of... Read More →


Tuesday June 16, 2020 11:45am - 12:30pm EDT

12:45pm EDT

Exhibitor Hour
Enter the Exhibitor Gallery to view all our amazing partners and the solutions that they can bring your business, and live chat availability.

Tuesday June 16, 2020 12:45pm - 2:00pm EDT

2:00pm EDT

Roundtable Discussions
Each roundtable discussion is limited to 12 participants and may be selected on a first-come, first-serve during the online registration process only.  Selecting "Add to my agenda" above does not guarantee or reserve a seat for you at a roundtable.

  • Integrity and open science - what should we do? (Member Proposal)
    • This roundtable discussion will explore the broad drivers in society for open access, including whether industry and the medical profession can and should consider patients as a legitimate audience for peer reviewed research. Barriers and mitigations to those barriers from the points of view of pharma clients and publishers will be considered.  This session qualifies for ISMPP CMPP credit 
  • Two peas in a pod - how can ORCID help, and then some (Member Proposal)
    • ORCID provides researchers with a unique persistent digital identifier that enables transparent and trustworthy connections between researchers, their affiliations and their contributions. Over the past couple of years, there has been an increase in the number of authors with a registered ORCID iD, but not all users realize the benefits beyond tracking publications. There is also a disconnect between the number of people with registered ORCID iDs and the number of authors that submit an iD during manuscript submission. Education of both authors and journals might therefore be key to increasing transparency and promoting discoverability of authors. This session qualifies for ISMPP CMPP credit 
  • Patient engagement and clinical trial summaries
    • This roundtable discussion will provide insights into the importance of patient engagement and enhance understanding of the new lay summary requirements. With lay summaries becoming a requirement that cannot be ignored (e.g. EU Clinical Trials Regulation 536/2014 [Article 37]), plus being another opportunity to actively engage and inform patients, this is a very timely session. It will educate medical publication professionals on what is needed, how it is done, and importantly why it is done.  This session qualifies for ISMPP CMPP credit 
  • Patient reported outcomes
    • Modifications in the healthcare landscape in recent years have increased the value and importance of PRO data, including general and disease-specific quality of life measures. Consequently, the reporting of such data has become a significant component of comprehensive publication plans. In this session, participants will discuss best practice in planning and developing PRO publications and identify key elements of high-quality PRO manuscripts. Participants also will be asked to describe their own company best practices, any PRO training they have received, and interactions with PRO department personnel to enable optimal interpretation and dissemination of data. Compliance concerns involving PRO publications will also be covered.  This session qualifies for ISMPP CMPP credit 
  • Preprints for Industry
    • In 2019, the new MedRxiv preprint server, developed with the YODA project at Yale, launched to expand the clinical scope of BioRxiv beyond clinical trials and epidemiology. Robust screening criteria, and restrictions (currently in development) will be utilized to safeguard patient and public health – content should not be used to influence clinical medicine. Will this service enable industry to share certain types of research in a transparent and collaborative environment or will adoption be prevented by concerns over promotion outside the convention of safe harbor that is peer review? Pros and cons will be discussed and the views of a traditional publisher towards the use of preprints alongside peer-reviewed publications will be explored.  This session qualifies for ISMPP CMPP credit 

Tuesday June 16, 2020 2:00pm - 2:45pm EDT

3:00pm EDT

Watch On Demand: Evolving the process and extending the reach of scientific platforms
Summary: 
Developing a detailed scientific platform is a fundamental first step of a strong publication plan. A well-developed, comprehensive scientific platform ensures internal alignment and consistent and clear language across all publications, medical communications, and beyond. Generation of scientific platforms consumes significant time and effort. However, if they are not developed properly, the final result may be a document lacking internal alignment with limited uptake and use. During this parallel session, we will focus on evolving best practices for building a robust and clinically relevant scientific platform. Key components of this detailed process include a comprehensive approach actively engaging key members from all functional groups of an interdisciplinary team at all stages of development.

This may include initial one-on-one interviews or small group discussions as well as interactive, collaborative cross-functional workshops later in the process. An additional valuable step that is often missed in the development process is the vetting of the scientific platform with selected external experts to ensure that it is credible, scientifically robust, clinically meaningful, and unbiased. The user experience for the scientific platform is just as important as the scientific content. With a wide variety of solutions now available, choosing the appropriate medium or mediums is crucial.

Lastly, proper training and roll out of the complete platform and format are essential for successful execution. Our goal is to educate on the evolving development of the scientific platform and ensure it is readily accessible, usable, and adaptable to ultimately increase the overall value and final usage.
This session qualifies for pharmacy CE credit

Learning objectives:
  • Learn about the evolving development of the scientific platform and how they can incorporate these changes into their scientific platforms
  • Gain a deeper understanding of the communication formats available today and how they can be applied to scientific platforms to increase comprehension, retention and ROI
  • Understand how to work with both internal and external stakeholders to ensure smooth development of the evolving scientific platform while successfully abiding by and navigating internal processes, compliance, and ensuring proper training
  • Ensure their scientific platforms will be more readily assessable, usable and adaptable for the end users to increase the overall value and final usage

Speakers
avatar for Christopher Spohr

Christopher Spohr

Creative Director, Ashfield Healthcare Communications, part of UDG Healthcare, plc
Christopher Spohr has a 20-year portfolio of success driving creative direction, strategic planning, and execution of digital & traditional marketing and communications plans in the pharmaceutical, healthcare, and events industries. As Creative Director at Ashfield Healthcare Communications... Read More →
avatar for Angela Jacobson

Angela Jacobson

Group Account Director, Ashfield Healthcare LLC
Angela is a Group Account Director at Ashfield Healthcare Communications based in Middletown, Connecticut. With more than 15 years of agency experience, Angela has led the development and delivery of both US and global publication plans across a variety of therapeutic areas, including... Read More →
avatar for Rebecca Rozich

Rebecca Rozich

Vice President, Medical and Scientific Services, Ashfield Healthcare LLC
Rebecca Rozich obtained a BA in Molecular Biology at Skidmore College and a PhD in Molecular Biology, Cell Biology, and Biochemistry from Brown University. During her graduate work, Rebecca established a valuable model system to help identify the progressive molecular and cellular... Read More →

Moderators
avatar for Ken Pomerantz

Ken Pomerantz

Senior Director, Global Scientific Communications, Alexion Pharmaceuticals, Inc.
Dr. Pomerantz has over 15 years of experience in Academic Medicine and Research, and over 20 years of experience in Medical Publications and Scientific Communications.After receiving his PhD in Physiology, he pursued post-doctoral research at the Columbia University College of Physicians... Read More →


Tuesday June 16, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: Individualizing communications: From concept to impact
The shift in health care towards precision medicine, patient-centricity, and improving health is disrupting the way we think about medical publications and scientific communications. This session focuses on the critical need to individualize communications to connect with our audiences on a human level, based not only on highly personalized clinical scenarios, but tailored to each individual’s content and channel preferences, to motivate positive changes in clinical decision-making, behaviors, and practices. We will also explore how we can form new types of partnerships and use current and emerging innovations to connect with and inspire our audiences.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Appreciate what precision medicine means for disease classification, with the possibility that every disease will become a rare disease with unique communication requirements
  • Understand the principles of evidence-driven scientific storytelling, based on deep audience understanding and appreciation of adult learning principles to connect with our audience on an individual level
  • Recognize how partnerships with a broad range of stakeholders can support individualized communications
  • Appreciate how current and emerging communication innovations are changing the way we think about scientific communications on an individual level

Speakers
avatar for Denise Bonen

Denise Bonen

Senior Scientific Director, Complete HealthVizion, a McCann Health Company
Denise Bonen is a Senior Scientific Director with Complete HealthVizion. She has more than 16 years’ of medical communications and scientific publishing experience. Denise has provided strategic counsel from a scientific and medical perspective for numerous global pharmaceutical... Read More →
avatar for Heather Abourjaily

Heather Abourjaily

Head of Global Scientific Communications - Pipeline, Vertex Pharmaceuticals
Dr. Abourjaily is an experienced Scientific Communications leader with over 15 years of progressively increasing responsibilities in the biopharmaceutical industry.  Her global scientific communication roles have encompassed Strategic Scientific Communications, Publications, Medical... Read More →
avatar for David Hogben

David Hogben

Director, Region USA & Global Multichannel, Complete Health Vizion
David has a total of 23 years experience in digital communications and marketing, with the last 11 years exclusively in medical communications. David is an experienced leader working with a range of senior clients across multiple therapy areas globally and regionally.  Applying... Read More →


Tuesday June 16, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: ISMPP Business Meeting
The ISMPP Business Meeting is an opportunity to hear about the Society’s accomplishments this year and plans for the coming year. Financials will be discussed along with an announcement of the new Board of Trustee members. Don’t miss a chance to be “in the know” about what ISMPP’s efforts to support its members.

Speakers
avatar for Robert Matheis

Robert Matheis

President and CEO, ISMPP
Dr. Matheis has a long tenure within scientific and medical communications and has been an integral part of ISMPP for more than a decade. He joined ISMPP in July of 2019 from his role as the Executive Director and Head of Global Scientific Communications at Celgene Corporation. Previously... Read More →
avatar for Catherine Skobe

Catherine Skobe

Chair, ISMPP Board of Trustees, Senior Director, Publications Management Team, Pfizer
Catherine Skobe is currently Sr Director, Publications Innovative Solutions Lead at Pfizer and co-leads the Publications Management Team. She has been at Pfizer since 2007 working across Pfizer's portfolio in various therapeutic areas at every stage of the product development life... Read More →
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →
avatar for Courtney Leo

Courtney Leo

Director, Integrated Medical Operations Services, Pfizer
Courtney began her pharmaceutical career in 1996 with experience across manufacturing, marketing, and medical at both Wyeth and Pfizer. She currently leads a global team with responsibilities for grant and financial management, medical publication operations, and vendor relationships... Read More →


Tuesday June 16, 2020 3:00pm - 4:00pm EDT
 
Wednesday, June 17
 

10:00am EDT

Opening Remarks
Welcome to Day 2 of ISMPP Virtual 16th Annual Meeting. Chair and Vice Chair of this year’s meeting, Carolyn Hustad and Kirsten Parr, will walk you through what you can expect today.

Speakers
avatar for Sharon Suntag

Sharon Suntag

Chair, ISMPP Abstract Committee; Director, Medical Strategy and Content, Medical and Patient Communications, IQVIA
Sharon has over 30 years' experience in health care communications, including 18 years at IQVIA. She leads the Medical and Patient Communications team of medical directors, writers and other subject matter experts in the strategy and development of medical communications and patient... Read More →
avatar for Carolyn Hustad

Carolyn Hustad

Chair, Annual Program Committee; Associate Vice President, Global Medical and Scientific Publications, MRL Scientific Affairs, Merck
Carolyn Hustad has been with Merck & Co., Inc. since 2001, starting as a medical writer, then progressing through roles of increasing responsibility until assuming leadership of the Global Scientific & Medical Publications department in 2016. She has a BS in Chemistry/Marine Science... Read More →
avatar for Kirsten Parr

Kirsten Parr

Vice Chair, Annual Program Committee; Head, CMC Connect Client Services, Complete Medical Communications
I am a life sciences graduate with a BSc (Hons) in Cell Biology and Immunology and a qualified teacher (PGCE). I have approaching 25 years’ experience in publications and medical communications and started my career in medical communications in 1995, working for a small agency in... Read More →


Wednesday June 17, 2020 10:00am - 10:15am EDT

10:15am EDT

Keynote: “Applying the ABT Framework to the Communication of Medicine”
Author and scientist-turned filmmaker Dr. Randy Olson will speak to the importance of science communication. Scientists are often poor communicators because of how they have been trained and need to be taught how to tell their science story in a way that their message is heard. This keynote will underscore the importance of effective communication and provide a tool that everyone can use to improve scientific communications.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Appreciate the importance of being taught how to communicate effectively
  • Be knowledgeable about the factors that contribute to effective communication to a wide range of audiences
  • Understand the principles of the ABT communication method

Speakers
avatar for Randy Olson

Randy Olson

Founder & Director, Story Circles Narrative Training
Randy Olson is the 2020 recipient of the John P. McGovern Award for Excellence in Biomedical Communication from the American Medical Writers Association. He is the founder and director of the Story Circles Narrative Training program working with scientists and communicators using... Read More →
avatar for Rob Pilbrow

Rob Pilbrow

Global Managing Director, Medical Writing, OPEN Health
Rob has spent 15 years in global medical communications in a variety of medical writing and leadership roles. In addition to his medical communications expertise, Rob has broad pharmaceutical industry experience across medical affairs, health economics and scientific publications... Read More →

Moderators
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →


Wednesday June 17, 2020 10:15am - 10:45am EDT

10:45am EDT

Exhibitor Break
Enter the Exhibitor Gallery to view all our amazing partners and the solutions that they can bring your business, and live chat availability.

Wednesday June 17, 2020 10:45am - 11:00am EDT

11:00am EDT

Poster 2.0: Creating better research posters
Summary
Current methods are not always effective in communicating research findings. The #betterposter movement is challenging the way we communicate research at physical science conferences. But are these posters really better? What are the opportunities and barriers to using this format? And what should we be doing in a virtual congress setting?
This session focus on the topic of research posters and how they can be improved to communicate science more effectively for industry-sponsored research. Debate will explore whether our profession should be re-examining its approach to scientific posters. Examples from those who have utilized the Poster 2.0 approach and other more visual formats, as well as potential challenges, will be discussed.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Recognize the current deficiencies in the traditional scientific poster format
  • Understand the benefits and challenges with a more streamlined poster design
  • Recognize poster format preferences among Congress attendees
  • Consider poster requirements in a virtual setting


Speakers
avatar for Mike Morrison

Mike Morrison

Science Communication Designer, University of Michigan
Mike Morrison is a former User Experience (UX) designer who quit his tech career to become a PhD student in Work Psychology. He’s trying to do two things in his career: 1) Bring User Experience design principles to science to help disseminate knowledge faster 2) Understand the psychological... Read More →

Moderators
avatar for Jason Gardner

Jason Gardner

Head of Scientific Services, CMC Connect
Jason Gardner holds the position of Head of Scientific Services at CMC Connect, McCann Health Medical Communications. Jason has an honours degree in biological sciences, a doctorate in neuroscience, and he is a Certified Medical Publication Professional. Jason began his career working... Read More →


Wednesday June 17, 2020 11:00am - 11:45am EDT

11:45am EDT

Break
Wednesday June 17, 2020 11:45am - 12:00pm EDT

12:00pm EDT

Patient involvement in medical communications: A live how-to guide
Summary
There is a growing demand from patients and the public for increased involvement in all stages of the medicine development lifecycle. Medical communications spans many of these stages, and practical guidance is needed to ensure ethical and effective patient involvement. This session will bring together stakeholders in this space to share their expertise throughrole play in 3 interactive scenarios, inviting the audience to bring any questions that they have.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Be aware of the scope of medical communications activities where patients can be involved
  • Understand best practice considerations (and approaches to avoid) for 3 activities: patient authorship of a peer-reviewed publication, patient involvement in an advisory board, and patient presentation at a scientific symposium
  • Consider perspectives from key stakeholders: patients, industry, and publications professionals
  • Be equipped to apply the practical guidance to discuss, plan and implement patient involvement activities in their own organizations

Speakers
avatar for Vanessa Pott

Vanessa Pott

Director, Global Patient Insights & Advocacy, Merck KGaA
The Patient Insights & Advocacy team partners with advocacy groups to support Merck’s vision of becoming the most patient-directed healthcare company, where insights and feedback from patients and carers shape behaviors and decisions across the continuum of research, development... Read More →
avatar for Lauri Arnstein

Lauri Arnstein

Patient Partnership Liaison, Envision Pharma Group
Dr. Lauri Arnstein holds an MA in Biological and Biomedical Sciences from the University of Cambridge, UK and completed her medical degree at University College London, UK. She practised as a junior doctor in London before becoming a medical writer in 2014. Her current role as Patient... Read More →
avatar for Trishna Bharadia

Trishna Bharadia

Health Advocate and Patient Engagement Champion
Trishna Bharadia is a multi-award winning health advocate and patient engagement champion. From the UK, she has worked across Europe and the world with multiple stakeholders to get the patient voice heard louder, stronger and more effectively throughout the entire healthcare journey... Read More →


Wednesday June 17, 2020 12:00pm - 12:40pm EDT

12:45pm EDT

Poster Hour
Visit the Poster module to see all of the the scientific poster displays!

Wednesday June 17, 2020 12:45pm - 2:00pm EDT

2:00pm EDT

Roundtable Discussions
Each roundtable discussion is limited to 12 participants and may be selected on a first-come, first-serve during the online registration process only.  Selecting "Add to my agenda" above does not guarantee or reserve a seat for you at a roundtable. 
  • How to nurture new clients into long-term relationships (Member Proposal)
    • Keeping clients happy so they continue to request projects is a win-win for both the client and the independent medical communication professional.   We’ll do 3 exercises to narrow the characteristics of your ideal clients.  We’ll discuss 5 issues that can turn off clients. We’ll also discuss 5 tips for nurturing clients into long-term relationships and maintaining that long-term relationship. Bring your experiences with both ideal clients and with difficult clients (anonymous) to discuss.  We’ll also mention one or two red flags that suggest the culture of the long-term client has changed.
  • The ten most important things to know when planning an advisory board (Member Proposal) 
    • This discussion will cover the importance of strategic planning and understanding the overall objectives and where an advisory-style meeting might fit in, as well as acknowledging the different approaches utilized within the pharmaceutical industry. We would then move on to identifying the key planning/development stages for an advisory board: pre-meeting planning, delivery of a successful meeting, post-meeting actions as well as any wider considerations.  This session qualifies for ISMPP CMPP credit 
  • What matters most if you want your paper read (Member Proposal) 
    • We have analyzed 5,286 manuscripts from the top 25 pharma companies to examine who is the typical 1st author, last author, author mix (internal vs external), total author number, author order and even title word count to determine if any of these correlate to citations. The results will provide you with a roadmap of an optimal authorship mix to have your data read.  This session qualifies for ISMPP CMPP credit 
  • Debate: Publication plain language summaries - scientific exchange or product promotion? (Member Proposal) 
    • Publication plain language summaries (PPLS) have been a hot topic of discussion for several years. The value of broadening the reach and enhancing the understanding of scientific research is clear. But why have pharmaceutical companies been so slow in adopting PPLS? Could it be that there is a perceived risk, where the boundary between scientific exchange and promotional activities is unclear or misunderstood? This discussion will attempt to uncover the arguments on both sides.  This session qualifies for ISMPP CMPP credit 
  • Digital and enhanced media options
    • Not too long ago, most clinical research publications were found in print journals and books. Today, many scientific and medical journals are published exclusively in digital form online and often offer enhancements such as audioslides, video abstracts, interactive, multimedia content, and more. This roundtable session will focus on available options for digital publishing and presentation and new features that are and will be available in the coming years. Participants will also hear a practical explanation of the benefits and risks, and will be asked to devise potential solutions for overcoming barriers to using this technology. Issues such as peer review, transparency, compliance and regulatory policies, author interactions, and understanding audience needs in the context of digital medical publication planning will also be discussed.  This session qualifies for ISMPP CMPP credit 

Wednesday June 17, 2020 2:00pm - 2:45pm EDT

3:00pm EDT

Watch On Demand: Advancing Health Literacy in Clinical Research: Clear Communications for Every Participant
Summary
In April 2018, the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center) convened a workgroup of diverse stakeholders—including patients and representatives from industry, academia, foundations, patient advocacy groups, nonprofit organizations, and government entities—to examine the issue of health literacy in clinical research. Over 18 months, the workgroup identified the challenges that low health literacy presents within the clinical research environment. In response, the workgroup developed and curated content to harness the opportunities that two-way communication can have when integrated throughout the entire clinical research life cycle. The workgroup designed targeted resources to help primary writers and reviewers of participant-facing materials, including funders, sponsors, investigators and their study teams, institutional review board members, and ethics committees. Join us for this session where practical guidance and the resulting toolkit will be shared.
This session qualifies for pharmacy CE credit

Learning objectives:
  • Explain the importance of health literacy to the clinical trial process
  • Understand the tools available to make participant-facing materials more literate
  • Employ the tools in practice


Speakers
avatar for Sylvia Baedorf Kassis

Sylvia Baedorf Kassis

Program Manager, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard
Sylvia Baedorf Kassis, MPH has over 20 years of clinical research-related experience in Canada and the United States of America. Her expertise includes the management of ethical/regulatory issues in research and clinical trial workforce training and capacity building. Most recently... Read More →

Moderators
avatar for Laurie Myers

Laurie Myers

Global Health Literacy Director, Merck & Co
Since 2010, Laurie has led Merck’s global health literacy efforts in support of improved patient communications, including medication labeling, packaging, clinical trial materials, lay summaries, and patient education. Laurie has worked to include respondents with low health literacy... Read More →


Wednesday June 17, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: Oral Presentations and Poster Winners Announcement
This session qualifies for ISMPP CMPP credit
  • Plain language summaries (PLS): how are we doing? Assessment of readability in peer-reviewed journals
  • Man or mouse: are lay-media headlines and scientific-publication titles true to the study population? - Jason Gardner, PhD, Head of Scientific Services, CMC Connect

Speakers
avatar for Jason Gardner

Jason Gardner

Head of Scientific Services, CMC Connect
Jason Gardner holds the position of Head of Scientific Services at CMC Connect, McCann Health Medical Communications. Jason has an honours degree in biological sciences, a doctorate in neuroscience, and he is a Certified Medical Publication Professional. Jason began his career working... Read More →
avatar for Judy Fallon

Judy Fallon

SVP, Medical Affairs & Scientific Communications, The Curry Rockefeller Group
During her more than 20 years of experience in medical communications, Judy has worked extensively developing and delivering medical affairs and medical publications deliverables. As a leader in the medical communications profession, Judy has led training workshops at the International... Read More →
avatar for Sharon Suntag

Sharon Suntag

Chair, ISMPP Abstract Committee; Director, Medical Strategy and Content, Medical and Patient Communications, IQVIA
Sharon has over 30 years' experience in health care communications, including 18 years at IQVIA. She leads the Medical and Patient Communications team of medical directors, writers and other subject matter experts in the strategy and development of medical communications and patient... Read More →


Wednesday June 17, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch on Demand: Putting the ‘drive’ in patient-driven publications
Summary: 
This session will be devoted to challenges/pitfalls/best practice and innovative approaches to setting up the author/contributor panels, developing and executing (in the articles) meaningful patient perspectives, and rolling out the content (open access, patient advocacy websites, and so on) of projects/initiatives to develop "patient-driven" publications.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Be able to identify considerations when approaching patient-advocates/patients for participation in patient-driven content development initiatives
  • Be able to plan content-development initiatives that involve participants with potentially disparate backgrounds and capabilities (with regards to medical publications) so that the resulting content is accessible by experts and lay readers (ie patients) alike, all within a collegial environment where appropriate compliance requirements are met
  • Recognize the diverse needs – including rationale – for publication dissemination of patient-driven content

Speakers
avatar for Suz Schrandt

Suz Schrandt

Patient Advocate - Arthritis Foundation, Founder and CEO of ExPPect LLC
Suz Schrandt is a patient and patient engagement engineer with a health and disability law and policy background. She is the Founder and CEO of ExPPect, a patient engagement initiative focused on improving healthcare and research through the expertise and partnership of skilled patient... Read More →
avatar for Dikran Toroser

Dikran Toroser

Director, Publication Planning Group Lead, Takeda
Dikran Toroser PhD, CMPP is a Director, Publication Group Lead, Rare Metabolic Diseases and Neurosciences. Dikran holds a PhD in Biochemistry/Molecular Biology (from Newcastle Uni, UK). His background in the pharmaceutical industry includes leading publications in many therapeutic... Read More →

Moderators
avatar for Michael Pellegrino

Michael Pellegrino

Counsultant
Michael Pellegrino, PhD, CMPP™ has been a leader in the medical communications arena for more than 20 years, playing integral roles in developing, managing, and executing domestic (US) and worldwide communications plans in a variety of therapy areas that include oncology/immuno-oncology... Read More →


Wednesday June 17, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: Thinking beyond the ordinary: Optimizing medical communications for rare diseases
Summary: 
“If you’ve seen one patient, you’re an expert. If you’ve seen two patients, you’re a world-renowned expert.” This opinion, expressed by an expert in an ultra-rare disease, underscores the intrinsic communication challenges for rare diseases. Rare diseases are often misdiagnosed, or there may be a significant delay between the presentation of symptoms and diagnosis. Additionally, there are very limited clinical trial data, magnifying the importance of effectively communicating available data. Despite these challenges, the passion of patients, caregivers, and physicians associated with rare diseases provides opportunities to reach beyond the traditional dissemination of trial endpoints.

By utilizing innovative medical communications strategies to reach diverse audiences and report on patient data, we can empower patients and physicians to recognize and care for patients with rare diseases. In this session, we will discuss several case studies that examine the roles of medical affairs, medical communications, and publication groups in medical education and scientific dissemination of rare diseases.

These case studies will highlight the development and modification of common tools, such as publication plans and scientific platforms, to suit the needs and opportunities of communicating on rare diseases. Additionally, we will provide examples of how medical communications can be used to expand and enhance physician networks and prepare others for appropriately diagnosing and treating patients. By the end of the session, the audience should gain knowledge about the communication challenges that are unique to rare diseases and be prepared to address these in several ways.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Tailor scientific platforms and plans for publications and medical affairs for rare diseases
  • Identify innovative ways to reach audiences
  • Leverage patient-level data to tell the scientific story
  • Use disease state education to expand the rare disease community

Speakers
avatar for Scott Baver

Scott Baver

Medical Affairs Professional
Scott has been in Medical Affairs for about a decade in various different capacities. He has spent his time as a Medical Affairs professional in multiple disease states but has a passion for rare disease. Scott has dedicated his career to coming up with novel solutions to bring awareness... Read More →
avatar for Jeff Stumpf

Jeff Stumpf

Scientific Director II, MedThink SciCom
As a Scientific Director II, Jeff provides scientific direction to internal writers and account staff, as well as clients and external authors. He ensures the quality of medical communications through management, peer review, and collaboration with clients to understand and meet their... Read More →


Wednesday June 17, 2020 3:00pm - 4:00pm EDT
 
Thursday, June 18
 

10:00am EDT

Opening Remarks
Welcome to the final day of ISMPP’s Virtual 16th Annual Meeting. ISMPP CEO Rob Matheis and Board of Trustees Chair Todd Parker walk you through Day 3 as we take a closer look to our evolving profession.

Speakers
avatar for Robert Matheis

Robert Matheis

President and CEO, ISMPP
Dr. Matheis has a long tenure within scientific and medical communications and has been an integral part of ISMPP for more than a decade. He joined ISMPP in July of 2019 from his role as the Executive Director and Head of Global Scientific Communications at Celgene Corporation. Previously... Read More →
avatar for Todd Parker

Todd Parker

Vice President, Managing Director, MedThink SciCom
As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience... Read More →


Thursday June 18, 2020 10:00am - 10:15am EDT

10:15am EDT

Keynote: How to Write a Scientific Masterpiece in 2020
Factors such as the rise of preprints and supplemental data, coupled with other changes, call for a nuanced approach to scientific writing and publishing. Corinne Williams, PhD, Senior Science Editor for the Journal of Clinical Investigation, will speak to manuscript expectations in the current day. Come learn how to be best prepared as we usher in a new decade of scientific exchange.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Appreciate the influence of factors such as the rise of preprints and supplemental data on the publication landscape 
  • Understand the current expectations of editors and publishers for scientific manuscripts
  • Be aware of how to successfully navigate these changing expectations

Speakers
avatar for Corinne Williams

Corinne Williams

Senior Science Editor, Journal of Clinical Investigation (JCI) and JCI Insight
Corinne Williams, PhD is Senior Science Editor for the Journal of Clinical Investigation (JCI) and JCI Insight. The JCI and JCI Insight are peer-reviewed journals that are self-published by the American Society for Clinical Investigation (ACSI), a medical honor society of physician-scientists... Read More →

Moderators
avatar for Carolyn Hustad

Carolyn Hustad

Chair, Annual Program Committee; Associate Vice President, Global Medical and Scientific Publications, MRL Scientific Affairs, Merck
Carolyn Hustad has been with Merck & Co., Inc. since 2001, starting as a medical writer, then progressing through roles of increasing responsibility until assuming leadership of the Global Scientific & Medical Publications department in 2016. She has a BS in Chemistry/Marine Science... Read More →


Thursday June 18, 2020 10:15am - 10:45am EDT

10:45am EDT

Break
Visit the Resources section to discover some of the new and exciting offerings from ISMPP on how you can connect with other members.  Jump into an ISMPP Connect Forum and share your opinion on a hot topic!

Thursday June 18, 2020 10:45am - 11:00am EDT

11:00am EDT

Synergizing Scientific Transparency: A Crash Course from National Academy of Sciences Discussions
Summary
Despite best efforts, scientific reproducibility remains low and contributes to the ultimate failure of many clinical candidates. The National Academy of Science has placed a particular focus on combatting this, producing three reports on the topic in as many years.  The most recent, "Reproducibility and Replicability in Science," was the subject of a working discussion designed to generate a consistent set of minimum standards. In this session, delegates from this recent work group will provide a crash course of the discussions, focused on what medical publishing professionals need to know. Open discussion will follow to encourage member perspective.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit

Learning objectives:
  • Generate research products that fit minimum standards frameworks on the horizon
  • Synergize efforts to achieve scientific transparency by providing the industry/medical communications point of view in open discussions
  • Predict research and manuscript preparation strategies necessary for addressing upcoming initiatives in scientific transparency

Speakers
avatar for David Mellor

David Mellor

Director of Policy Initiatives, Center for Open Science
David Mellor leads the policy and incentive programs at the Center for Open Science in order to reward increased transparency and reduced bias in scientific research. These include policies for publishers and funders in the Transparency and Openness Promotion Guidelines (TOP: cos... Read More →
avatar for Leslie McIntosh

Leslie McIntosh

CEO, Ripeta. Executive Director at the Research Data Alliance
Dr. Leslie McIntosh, PhD, MPH currently serves in two positions. She is the inaugural Executive Director for the Research Data Alliance – US (RDA-US), which is part of a global organization developing recommendations for data sharing and interoperability. She is also the founder... Read More →

Moderators
avatar for Richard W Davis IV

Richard W Davis IV

Associate Editor, Molecular Cancer Therapeutics, American Association for Cancer Research
Richard Davis serves as the Associate Editor for Molecular Cancer Therapeutics at the American Association for Cancer Research. During his time at the journal, he implemented the new “First Disclosure” article type to promote the translation of clinical candidates in oncology... Read More →


Thursday June 18, 2020 11:00am - 11:45am EDT

11:45am EDT

Break
Thursday June 18, 2020 11:45am - 12:00pm EDT

12:00pm EDT

How Do You Do That? An Interactive Panel Discussion on Hot Topics in Medical Communications
Summary:
Navigating common questions and potential challenges associated with medical communications can be difficult. While guidelines exist to support our industry, many issues we face fall within a ‘gray area’ that is not clearly defined. Our panel of expert pharmaceutical biotech and agency medical communications professionals will share their insights and discuss various approaches to addressing some of these everyday questions. Topics for inclusion in the panel presentation will be determined based on an ISMPP member-driven survey using ISMPP’s LinkedIn group site or membership database. Respondents, which may include individuals from pharmaceutical biotech companies, medical journals, health care associations/societies, and medical communications agencies, will be asked to share their top 5 questions and potential challenges associated with executing medical communications.

Potential topics may include navigating copyright permissions, identifying desirable attributes of a strategic agency or collaborative industry partner, troubleshooting compliance challenges in the use of publication management tools, circumstances surrounding removal of authors, adherence to timelines, pros and cons of streamlined versus more traditional poster formats, and advising authors on conflict-of-interest disclosures. A few informational slides on the selected topics will be shared before our panel discusses their practical strategies and solutions to these common challenges. Case examples will be used when appropriate to engage and promote interaction. Additional questions for the panel and polling may be obtained live via an audience response system, if deemed appropriate by ISMPP.

Through this session, attendees will gain practical insights into navigating some of the common questions and potential challenges surrounding medical communications.
This session qualifies for ISMPP CMPP credit

Learning objectives:
  • Recognize some of the common questions and potential challenges associated with medical communications from both the pharmaceutical biotech and agency perspectives
  • Learn various practical solutions to these challenges from an expert panel of medical communications professionals, including both pharmaceutical biotech and agency representatives
  • Expand their available armamentarium for executing successful medical communications

Speakers
avatar for Alley Sullivan

Alley Sullivan

Senior Account Director, The Lockwood Group
Alley brings 10 years of experience in medical communication to Lockwood. Over the course of Alley’s career she has worked with both large and small pharmaceutical and biotech clients in a variety of product lifecycles both globally and US focused.  Her breadth of experience in... Read More →
avatar for Alyssa Bowling

Alyssa Bowling

Senior Manager, Scientific Communications, Sunovion
Alyssa Bowling is a Senior Manager of Scientific Communications at Sunovion Pharmaceuticals, primarily supporting publications and Medical Affairs initiatives for Sunovion’s neurology portfolio. She holds a Bachelor of Science degree in neuroscience and a Doctorate in Pharmacy from... Read More →
avatar for Dee Bojanic

Dee Bojanic

Global Publications Lead, Gilead
Dee Bojanic, PhD, CMPP is the Head of Global Publications at Gilead Sciences. In her role, Dee is responsible for leading global publications team; establishing and implementing Gilead¬øs publication policy; optimizing and implementing the systems for publication development and... Read More →
avatar for Samantha Koth

Samantha Koth

Director, Medical Affairs, Sunovion
Samantha Koth serves as Director, Medical Affairs Operations at Sunovion Pharmaceuticals where she oversees the Scientific Communications, Grants Program (independent medical education and investigator-initiated studies), amongst other medical affairs functions such as corporate memberships... Read More →
avatar for Marissa Nolan

Marissa Nolan

VP, Group Scientific Director, The Lockwood Group
Marissa Nolan has 10+ years of medical education and publication planning experience. She is proficient in developing scientific content and provides strategic and scientific insight for all types of medical communications.  Marissa joined the Lockwood Group in 2014 where she oversees... Read More →


Thursday June 18, 2020 12:00pm - 12:45pm EDT

12:45pm EDT

Exhibitor Hour
Enter the Exhibitor Gallery to view all our amazing partners and the solutions that they can bring your business, and live chat availability.

Thursday June 18, 2020 12:45pm - 2:00pm EDT

2:00pm EDT

Roundtable Discussions
Each roundtable discussion is limited to 12 participants and may be selected on a first-come, first-serve during the online registration process only.  Selecting "Add to my agenda" above does not guarantee or reserve a seat for you at a roundtable.
  • Hybrid positions - an increasing trend in publications (Member Proposal) 
    • The modern medical publication professional’s job description is under rapid evolution. In the recent past, many positions were strictly writing or planning-based. However, modern-day publication professionals are increasingly being asked to perform aspects of numerous jobs. These multifaceted positions could be described as being “hybrid.” A hybrid professional may need to carry out many functions by way of their flexible job description, or they may need to “wear many hats” due to being part of a small publications department. These positions often offer the best of numerous worlds, and often lead to significant career growth and expanded skill sets. Join this conversation around the evolving role of the medical publication professional and what may lie in the future.
  • Tempted by the Dark Side? Learning from those who went before (Member Proposal) 
    • Med comms is constantly changing and as professionals, we need to adapt to new challenges. This session is aimed at those who might be thinking about their next career move as going over to the "Dark Side" in terms of industry vs agency, and/or publications vs medical affairs. The "Dark Side" is, of course, subjective, but whether you're a Jedi or a Sith, this is an opportunity to hear from those who have moved, to learn about what drove their decision to switch, and differences between their original/current focus. We will explore differences in roles, challenges/rewards of switching, and what you might like to know before committing to your future path...
  • Avoiding errors in peer reviewed medical science literature (Member Proposal) 
    • The reported incidence of errata in peer-reviewed publications is approximately 1-2%. However, work conducted by Constantino, and published in 2013, suggest from a retrospective analysis of 200 sequential publications across 3 of the highest impact medical journals that the actual underlying incidence of errors is far higher - in some cases even exceeding 70%. This discussion will touch on a combination of retrospective and prospective studies to highlight the issue, and bring learnings from studies that have looked at improving post-surgical outcomes, along with approaches to improving safety in the airline industry to help reduce errors and improve overall quality in peer-reviewed medical publications.  This session qualifies for ISMPP CMPP credit 
  • Transparency in publication development: Scientific contributions of medical writers
    • Individuals throughout the medical communications community have agreed that many medical writers provide scientific and intellectual contributions to the publications they write. However, the breadth of these contributions vary on a case-by-case basis and are not transparently reflected in the current standard of acknowledging general “medical writing” and/or “editorial support.” This roundtable will examine the evolution of transparency around recognition of scientific and intellectual contributions from medical writers and will discuss current perceptions and potential steps that can be taken to make the contributions of medical writers even more transparent.  This session qualifies for ISMPP CMPP credit 
  • A natural selection debate: Promotional brand medical education or disease state medical education (Member Proposal) 
    • With the ever-increasing number of treatment options available to patients, healthcare providers need to be kept up to date with the scientific advancements of new medicines. Industry companies play a role in informing healthcare professionals in a way that should always be appropriate and support good patient care. This information exchange is often categorized as promotional, non-promotional, educational, or scientific; but the distinction between them is often challenging to ascertain. Marketing teams champion branded promotional medical education as an opportunity to link science with engaging and emotive stories that help highlight the clinical need for which the product provides the solution. Medical teams focus on scientific exchange and disease state medical education with the aim of maintaining, developing, or increasing the knowledge, skills, and professional performance of HCPs. But which is best in which circumstances? This interactive discussion will examine promotional medical education against disease state medical education to examine each regarding their advantages, limitations, compliance issues, US vs EU vs rest of world considerations, FDA and EMEA positions, physicians and patient perspectives, definitions of unmet needs, and issues with localization.  This session qualifies for ISMPP CMPP credit 

Thursday June 18, 2020 2:00pm - 2:45pm EDT

3:00pm EDT

Watch On Demand: Best practices in aligning publication content and strategic planning with Medical Information Services and Medical Science Liaison (MSL) groups
Summary
Medical Information and MSL groups are important strategic stakeholders in the publication planning process. Best practices allow an open forum for a bidirectional relationship between these groups and publication planning. Medical Information and MSL groups can provide valuable insights from the field (regional and/or global perspectives) to the publication team for consideration regarding unmet needs and frequent questions that can generate new analyses for subsequent publication development. In turn, publication content is then utilized by Medical Communication, Medical Information, and MSL groups to create content in various formats and to communicate with HCPs, payers, and other stakeholders.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit
 
Learning objectives:
  • Recognize the value of establishing a bidirectional relationship between Medical Information/MSLs and publication planning groups
  • Identify examples of insights provided by Medical Information/MSLs that can provide the basis for future publications
  • Discuss how to establish a cohesive approach to optimize dissemination of consistent medical content

Speakers
avatar for Elisa Park

Elisa Park

Associate Director, Global Medical Information, Jazz
Elisa Park is Associate Director, Global Medical Information at Jazz Pharmaceuticals and provides support for the neuroscience franchise. She began her career as a pharmacist in various pharmacy practice settings prior to joining the pharmaceutical industry. Elisa earned her Doctor... Read More →
avatar for Brian Scheckner

Brian Scheckner

Senior Director, Medical Communications, Neuroscience Franchise
Brian Scheckner, PharmD, BCPP, CMPP, has worked in the pharmaceutical industry since 1999, serving primarily in publication and medical communication leadership roles. Brian is currently Senior Director, Medical Communications, at Jazz Pharmaceuticals, with publication/medical communication... Read More →
avatar for Mike Trabold

Mike Trabold

Associate Director, Global Medical Information, Medical Science Liaisons
Michael Trabold is the Associate Director, Medical Science Liaisons for the Neuroscience/Sleep franchise at Jazz Pharmaceuticals in the US. He has held various medical affairs positions in the pharmaceutical industry with several companies, ranging from small to mid-size companies... Read More →
avatar for Diane Sloan

Diane Sloan

Executive Medical Director, Peloton Advantage


Thursday June 18, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: Mapping and Navigating the New Frontier of Gene Therapy Publication Planning
Join us for an interactive panel discussion among industry publications experts around the considerations and challenges for publication planning in support of one of the most rapidly evolving areas of therapeutic development – gene therapies.  Communications around gene therapies may require adjustment from conventional experience regarding timing and scope of publication plans. Panelists will educate on similarities and differences regarding publication planning for conventional therapies vs those for gene therapies and how to best navigate the different requirements.
This session qualifies for ISMPP CMPP credit
This session qualifies for pharmacy CE credit


Speakers
avatar for Robin LeWinter

Robin LeWinter

Senior Director, Medical Communications, Orchard Therapeutics
Robin LeWinter obtained her PhD in Neuroscience from the University of California, San Francisco, followed by a post-doc at SRI, International. Robin has over 15 years of experience in the field of Medical Communications and Publications at several small and mid-sized pharmaceutical... Read More →
avatar for Eugene Tombler

Eugene Tombler

Medical Insights Director, CMC - Connect
Gene Tombler has worked in medical communications and continuing education in various roles from medical writer, executive medical director and vice president for over sixteen years. He has served three years in his current position as the Medical Insights Director of CMC-Connect... Read More →
avatar for Kate Lewis

Kate Lewis

VP, Program Lead, Beta-Thalassemia
Kate Lewis, MA is vice president and program lead at bluebird bio, a leading developer of gene therapies for severe genetic diseases and cancer. She currently leads bluebird’s beta-thalassemia gene therapy program, developing betibeglogene autotemcel, an ex vivo, lentiviral-vector-based... Read More →


Thursday June 18, 2020 3:00pm - 4:00pm EDT

3:00pm EDT

Watch On Demand: So you have a scientific platform – what next?
Summary
Much time and effort is put into the development of an optimal scientific platform from an early stage of development, including the process we go through to attain optimal internal stakeholder alignment and the careful selection of words within the scientific statements. However, if the roll-out and follow up on the scientific platform is not planned carefully, the time spent developing the platform has been wasted. This session will explore the optimal approaches to encourage engagement with and support best use of your scientific platform.
This session qualifies for pharmacy CE credit

Learning objectives:
  • Understand optimal approaches to encourage engagement with and support best use of your scientific platform 
  • Be knowledgeable in the roll-out to global, regional and county-specific stakeholders
  • Be aware of platform options and how to keep technology up-to-date
  • Appreciate the role of metrics in tracking success
 

Speakers
avatar for Alison Humphries

Alison Humphries

Medical Insights Director, CMC Connect
Alison Humphries is Director of Medical Strategy at CMC CONNECT and her portfolio career has taken her from general practice via clinical research to medical communications, where she has enjoys bringing her therapy area insights to bear on a range of strategic and tactical projects... Read More →
avatar for Karen King

Karen King

Head of Growth and Development, CMC Affinity
Karen King is Head of Medical Strategy, Growth & Development at CMC AFFINITY and has over 20 years’ experience working in medical communications.  Karen gained her PhD in Oncology from the Paterston Institute of Cancer Research, Manchester, UK. Her passions span development of... Read More →
avatar for Debbie Walton

Debbie Walton

Global Publications Manager, Merck
Debbie Walton is an Associate Director of Publication Management in the Global Scientific and Medical Publications group at Merck and Co, Inc. She has been in the group for 7 years and is currently the lead Publication Manager for Gardasil/Gardasil 9, Ervebo, and Vaxelis. In this... Read More →


Thursday June 18, 2020 3:00pm - 4:00pm EDT